Inventor · disambiguated record
Godwin Pais
Also filed as: PAIS GODWIN · PAIS GODWIN C · PAIS GODWIN CLARENCE GILROY
63 granted patents·12 pending applications·1,107 citations·filing 2002–2024
99Inventor score
Files withACHILLION PHARMACEUTICALS INC66BRADBURY BARTON JAMES5WILES JASON ALLAN2BURKE TERRENCE R1PHADKE AVINASH1
Top patents by PatentIndex Score
75 records- 0199US10822352B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·20 cites·17 claims
- 0299US10550140B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 4, 2020·27 cites·20 claims
- 0399US10301336B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·27 cites·20 claims
- 0499US10287301B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·28 cites·18 claims
- 0599US10189869B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Jan 29, 2019·27 cites·36 claims
- 0699US10138225B2Amide compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Nov 27, 2018·33 cites·31 claims
- 0799US10106563B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·30 cites·20 claims
- 0899US10100072B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 16, 2018·27 cites·53 claims
- 0999US10092547B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·19 cites·14 claims
- 1099US10081645B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Sep 25, 2018·27 cites·40 claims
- 1199US10011612B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jul 3, 2018·30 cites·3 claims
- 1299US10005802B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 26, 2018·27 cites·38 claims
- 1399US10000516B2Phosphonate compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 19, 2018·28 cites·28 claims
- 1499US9828396B2Alkyne compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·30 cites·40 claims
- 1599US9796741B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Oct 24, 2017·37 cites·50 claims
- 1699US9758537B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Sep 12, 2017·27 cites·39 claims
- 1799US9732103B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·32 cites·29 claims
- 1899US9732104B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·30 cites·68 claims
- 1999US9695205B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·32 cites·56 claims
- 2099US9663543B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·32 cites·49 claims
- 2199US9598446B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·33 cites·7 claims
- 2298US11708351B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·8 cites·17 claims
- 2398US11407738B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·16 cites·12 claims
- 2498US11084800B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·18 cites·11 claims
- 2598US10919884B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 16, 2021·20 cites·12 claims
- 2698US10906887B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 2, 2021·20 cites·12 claims
- 2798US10689409B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jun 23, 2020·9 cites·23 claims
- 2898US10662175B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·20 claims
- 2998US10464956B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 5, 2019·21 cites·24 claims
- 3098US10428095B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 1, 2019·21 cites·2 claims
- 3198US10428094B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 1, 2019·21 cites·40 claims
- 3298US10370394B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·23 cites·35 claims
- 3398US10253053B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Apr 9, 2019·22 cites·20 claims
- 3498US10087203B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·25 cites·21 claims
- 3597US12006307B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2022·Granted Jun 11, 2024·3 cites·7 claims
- 3697US11447465B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·16 cites·8 claims
- 3797US11001600B2Disubstituted compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 11, 2021·16 cites·9 claims
- 3897US10807952B2Compounds for treatment of immune inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·20 cites·13 claims
- 3997US10660876B2Amino compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·14 claims
- 4096US12162860B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·2 cites·20 claims
- 4196US10092584B2Compounds for the treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Oct 9, 2018·28 cites·41 claims
- 4296US9273082B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·14 cites·17 claims
- 4395US12139497B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Nov 12, 2024·1 cites·20 claims
- 4495US11649229B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
- 4595US11649223B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
- 4695US10385097B2Ether compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Aug 20, 2019·23 cites·27 claims
- 4795US9125904B1Biphenyl imidazoles and related compounds useful for treating HCV infectionsWILES JASON ALLAN·Filed 2011·Granted Sep 8, 2015·17 cites·7 claims
- 4895US8809313B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infectionsWILES JASON ALLAN·Filed 2012·Granted Aug 19, 2014·15 cites·32 claims
- 4991US12065459B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 20, 2024·3 cites·20 claims
- 5091US9474742B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Oct 25, 2016·3 cites·41 claims
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →